2013
DOI: 10.1002/14651858.cd001245.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

3
90
2
7

Year Published

2013
2013
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 133 publications
(102 citation statements)
references
References 56 publications
3
90
2
7
Order By: Relevance
“…It is therefore still unknown whether the application of antifibrinolytic therapy is really useful. 23 Currently, a prospective trial investigates whether ultraearly tranexamic acid administration prevents rebleeding and subsequently also leads to a better outcome. 24 It is clear that emergency aneurysm repair avoids the possible use of antifibrinolytic therapy.…”
Section: Discussionmentioning
confidence: 99%
“…It is therefore still unknown whether the application of antifibrinolytic therapy is really useful. 23 Currently, a prospective trial investigates whether ultraearly tranexamic acid administration prevents rebleeding and subsequently also leads to a better outcome. 24 It is clear that emergency aneurysm repair avoids the possible use of antifibrinolytic therapy.…”
Section: Discussionmentioning
confidence: 99%
“…16 17 For example, raised intracranial pressure can lead to cerebral hypoperfusion. [18][19][20] Thrombotic disseminated intravascular coagulation might increase the risk of cerebral microthrombi, which are often seen in the brains of patients with traumatic brain injury who have died. 21…”
mentioning
confidence: 99%
“…Длительное применение антифи-бринолитиков с целью уменьшить риск повторного кровотечения может еще больше снижать эффек-тивность консервативного лечения церебральной ишемии [8].…”
Section: Discussionunclassified